Anderson, VM; Fernando, KTM; Davies, GR; Rashid, W; Frost, C; Fox, NC; (2007) Cerebral atrophy measurement in clinically isolated syndromes and relapsing remitting multiple sclerosis: A comparison of registration-based methods. Journal of neuroimaging, 17 (1). pp. 61-68. ISSN 1051-2284 DOI: https://doi.org/10.1111/j.1552-6569.2006.00081.x Full text not available from this repository.

Chataway, J; Porter, B; Riazi, A; Heaney, D; Watt, H; Hobart, J; Thompson, A; (2006) Home versus outpatient administration of intravenous steroids for multiple-sclerosis relapses: a randomised controlled trial. Lancet neurology, 5 (7). pp. 565-571. ISSN 1474-4422 DOI: https://doi.org/10.1016/S1474-4422(06)70450-1 Full text not available from this repository.

Chong, MS; Wolff, K; Wise, K; Tanton, C; Winstock, A; Silber, E; (2006) Cannabis use in patients with multiple sclerosis. Multiple sclerosis (Houndmills, Basingstoke, England), 12 (5). pp. 646-651. ISSN 1352-4585 DOI: https://doi.org/10.1177/135248506070947 Full text not available from this repository.

Hickman, SJ; Kapoor, R; Jones, SJ; Altmann, DR; Plant, GT; Miller, DH; (2003) Corticosteroids do not prevent optic nerve atrophy following optic neuritis. Journal of neurology, neurosurgery, and psychiatry, 74 (8). pp. 1139-41. ISSN 0022-3050 DOI: https://doi.org/10.1136/jnnp.74.8.1139 Full text not available from this repository.

Hobart, J; Freeman, J; Lamping, D; Fitzpatrick, R; Thompson, A; (2001) The SF-36 in multiple sclerosis: why basic assumptions must be tested. Journal of neurology, neurosurgery, and psychiatry, 71 (3). pp. 363-70. ISSN 0022-3050 https://researchonline.lshtm.ac.uk/id/eprint/16936 Full text not available from this repository.

Hobart, J; Lamping, D; Fitzpatrick, R; Riazi, A; Thompson, A; (2001) The Multiple Sclerosis Impact Scale (MSIS-29) - A new patient- based outcome measure. Brain, 124 (Pt 5). pp. 962-73. ISSN 0006-8950 https://researchonline.lshtm.ac.uk/id/eprint/16934 Full text not available from this repository.

Hobart, JC; Riazi, A; Lamping, DL; Fitzpatrick, R; Thompson, AJ; (2003) Measuring the impact of MS on walking ability - The 12-Item MS Walking Scale (MSWS-12). Neurology, 60 (1). pp. 31-6. ISSN 0028-3878 https://researchonline.lshtm.ac.uk/id/eprint/16943 Full text not available from this repository.

McMichael, AJ; Hall, AJ; (2001) Multiple sclerosis and ultraviolet radiation: Time to shed more light. Neuroepidemiology, 20 (3). pp. 165-7. ISSN 0251-5350 https://researchonline.lshtm.ac.uk/id/eprint/16758 Full text not available from this repository.

Miller, DH; Altmann, DR; Chard, DT; (2012) Advances in Imaging to Support the Development of Novel Therapies for Multiple Sclerosis. Clinical pharmacology and therapeutics, 91 (4). pp. 621-634. ISSN 0009-9236 DOI: https://doi.org/10.1038/clpt.2011.349 Full text not available from this repository.

Munger, KL; Delorenze, GN; Levin, LI; Rubertone, MV; Vogelman, JH; Peck, CA; Peeling, RW; Orentreich, N; Ascherio, A; (2004) A prospective study of Chlamydia pneumoniae infection and risk of MS in two US cohorts. Neurology, 62 (10). pp. 1799-803. ISSN 0028-3878 https://researchonline.lshtm.ac.uk/id/eprint/4690 Full text not available from this repository.

Munger, KL; Peeling, RW; Hernan, MA; Chasan-Taber, L; Olek, MJ; Hankinson, SE; Hunter, D; Ascherio, A; (2003) Infection with Chlamydia pneumoniae and risk of multiple sclerosis. Epidemiology (Cambridge, Mass), 14 (2). pp. 141-7. ISSN 1044-3983 DOI: https://doi.org/10.1097/01.EDE.0000050699.23957.8E Full text not available from this repository.

Prosperini, L; Gallo, V; Petsas, N; Borriello, G; Pozzilli, C; (2009) One-year MRI scan predicts clinical response to interferon beta in multiple sclerosis. European journal of neurology, 16 (11). pp. 1202-9. ISSN 1351-5101 DOI: https://doi.org/10.1111/j.1468-1331.2009.02708.x Full text not available from this repository.

Riazi, A; Hobart, JC; Lamping, DL; Fitzpatrick, R; Thompson, AJ; (2003) Evidence-based measurement in multiple sclerosis: the psychometric properties of the physical and psychological dimensions of three quality of life rating scales. Multiple sclerosis (Houndmills, Basingstoke, England), 9 (4). pp. 411-419. ISSN 1352-4585 DOI: https://doi.org/10.1191/1352458503ms929oa Full text not available from this repository.

Riazi, A; Hobart, JC; Lamping, DL; Fitzpatrick, R; Thompson, AJ; (2002) Multiple Sclerosis Impact Scale (MSIS-29): reliability and validity in hospital based samples. Journal of neurology, neurosurgery, and psychiatry, 73 (6). pp. 701-4. ISSN 0022-3050 DOI: https://doi.org/10.1136/jnnp.73.6.701 Full text not available from this repository.

Schmierer, K; Tozer, DJ; Scaravilli, F; Altmann, DR; Barker, GJ; Tofts, PS; Miller, DH; (2007) Quantitative magnetization transfer imaging in postmortem multiple sclerosis brain. Journal of magnetic resonance imaging, 26 (1). pp. 41-51. ISSN 1053-1807 DOI: https://doi.org/10.1002/jmri.20984 Full text not available from this repository.